Browse by:
Research & Development

Karyopharm finds clinical partner, possible new uses for cancer drug

Emily Micucci |

Karyopharm Therapeutics of Natick has produced promising results as it develops its cancer drug, KPT-330. Now, the startup is exploring other potential applications for its technology.

Raytheon CEO to retire; successor named

Rick Saia |

The CEO of Raytheon will retire at the end of March and will be replaced by the defense contractor's executive vice president and chief operating officer, the Waltham-based company announced today.

Karyopharm IPO success part of the biotech boom

Emily Micucci |

The decision to take a company public isn't an easy one, said Paul Brannelly, senior vice president of finance and administration at Karyopharm Therapeutics in Natick. The money and time spent on...

Acton's Psychemedics Eyes Possible Brazil Expansion

Emily Micucci |

With one of the highest traffic death rates in the Western Hemisphere, Brazil recently took a bold step by requiring all professional drivers to pass a hair drug test when they apply for license...

Copyright 2014 New England Business Media